EndoChoice

Endo Choice

Medical Devices, Wills Road, Alpharetta, , 30009, Georgia, 11810, United States, 201-500 Employees

endochoice.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +17*********

Who is ENDOCHOICE

Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices an...

Read More

map
  • 11810 Wills Road, Alpharetta, Georgia, 30009, United States Headquarters: 11810 Wills Road, Alpharetta, Georgia, 30009, United States
  • 2008 Date Founded: 2008
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ENDOCHOICE

EndoChoice Org Chart and Mapping

Employees

Similar Companies to EndoChoice

Boston Scientific

  • 10001+ 10001+
  • 1 Billion and Over $ 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding EndoChoice

Answer: EndoChoice's headquarters are located at Wills Road, Alpharetta, , 30009, Georgia, 11810, United States

Answer: EndoChoice's phone number is +17*********

Answer: EndoChoice's official website is https://endochoice.com

Answer: EndoChoice's revenue is $25 Million to $50 Million

Answer: EndoChoice's SIC: 3841

Answer: EndoChoice's NAICS: 339112

Answer: EndoChoice has 201-500 employees

Answer: EndoChoice is in Medical Devices

Answer: EndoChoice top competitors include: Boston Scientific

Answer: EndoChoice contact info: Phone number: +17********* Website: https://endochoice.com

Answer: Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse).

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access